Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sildenafil for Preservation of Erectile Function in Prostate Cancer Patients
NCT00142506Phase 3Completed
- Sponsor
- Memorial Sloan Kettering Cancer Center
- Start
- Feb 2005
- Primary completion
- Apr 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of ASP-001 in erectile dysfunction (ED), sponsored by Memorial Sloan Kettering Cancer Center. Primary endpoint: Assessment of Erectile Dysfunction at 24 months. Started Feb 2005; status: completed.
02
Drugs
ASP-001
03
Conditions
erectile dysfunction (ED)
Beyond the preview
Go deeper on NCT00142506.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00142506.